Over 90 Total Lots Up For Auction at One Location - WA 04/08

Filip Swirski

Mount Sinai appoints director of new Cardiovascular Research Institute
August 03, 2021
Filip Swirski
(New York, NY – July 21, 2021) – Mount Sinai Health System has appointed Filip Swirski, PhD, an internationally recognized leader in cardiovascular immunology research, to its faculty. Dr. Swirski will be the inaugural Director of the Cardiovascular Research Institute at the Icahn School of Medicine of Mount Sinai, which launched this summer.

"I am very excited to join the Mount Sinai community and take on this new and important role," says Dr. Swirski, who will also be the Arthur and Janet C. Ross Professor of Medicine (Cardiology) and Professor of Diagnostic, Molecular, and Interventional Radiology. "The Cardiovascular Research Institute will experience rapid growth over the next several years as it expands thematically and builds links with other Institutes and Departments. Together with Cardiology, we will build an international powerhouse for cardiovascular research. We will focus on lifestyle and prevention, systems physiology and bioengineering, and genomic medicine."

Dr. Swirski has made groundbreaking discoveries on the role of immunity and inflammation in atherosclerosis—the buildup of plaque along artery walls—and its complications. As Director of the Cardiovascular Research Institute, Dr. Swirski will build and lead a vibrant and collaborative multidisciplinary team that will make the institute a global hub for fundamental and translational cardiovascular science within the context of the hematologic, immune, metabolic, and nervous systems.
stats
DOTmed text ad

Reveal Mobi Pro now available for sale in the US

Reveal Mobi Pro integrates the Reveal 35C detector with SpectralDR technology into a modern mobile X-ray solution. Mobi Pro allows for simultaneous acquisition of conventional & dual-energy images with a single exposure. Contact us for a demo at no cost.

stats
Additionally, Dr. Swirski will hold positions in Mount Sinai's Precision Immunology Institute and BioMedical Engineering and Imaging Institute.

Before joining Mount Sinai, Dr. Swirski was a Professor at Harvard Medical School and a Principal Investigator at Massachusetts General Hospital. His latest work there was recently published in Nature: he led a team to discover a signaling pathway in humans and mice that helps modify inflammation to protect against Alzheimer's disease. The findings may lead to promising new therapeutic interventions for the progressive brain disorder.

Dr. Swirski obtained his PhD at McMaster University in Hamilton, Canada, and completed postdoctoral studies at Brigham and Women's Hospital in Boston. He is a highly cited researcher and is the recipient of numerous prestigious awards including the Jeffrey M. Hoeg Award and the Established Investigator Award from the American Heart Association, as well as the Outstanding Investigator Award from the National Heart, Lung, and Blood Institute. He is the American Coordinator of a Leducq Foundation Transatlantic Network of Excellence, sits on numerous editorial and scientific advisory boards, and has consulted for several biotech companies.

"This is a spectacular recruitment for Mount Sinai Heart. We look forward to the exciting scientific leadership that he will bring to our Cardiovascular Research Institute," says Valentin Fuster, MD, PhD, Director of Mount Sinai Heart and Physician-in-Chief of The Mount Sinai Hospital.


About the Mount Sinai Health System
The Mount Sinai Health System is New York City's largest academic medical system, encompassing eight hospitals, a leading medical school, and a vast network of ambulatory practices throughout the greater New York region.

You Must Be Logged In To Post A Comment